Read More
Biotech and pharma firms face ever-tightening safety and regulatory requirements. Global vacancies in pharmacovigilance (PV) have surged: new safety-reporting standards mean companies are hiring record numbers of drug-safety associates, scientists, and analysts. At the same time, regulators such as the FDA and EMA are increasing scrutiny, so bigger PV teams are needed for case review, signal de read more..